Benzinga's Top #PreMarket Losers
March 31, 2015 at 08:21 AM EDT
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) shares declined 16.74% to $1.94 in pre-market trading. Synta Pharmaceuticals launched a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.